Design, synthesis, in silico and in vitro studies of novel 4-methylthiazole-5-carboxylic acid derivatives as potent anti-cancer agents. 2014

Ravendra Babu Kilaru, and Koteswara Rao Valasani, and Nanda Kumar Yellapu, and Hari Prasad Osuru, and Chandra Sekhar Kuruva, and Bhaskar Matcha, and Naga Raju Chamarthi
Department of Chemistry, Sri Venkateswara University, Tirupati 517502, India; Mylan Laboratories Ltd, CRD, Anrich Industrial Estate, Bollaram, Hyderabad 502325, India.

Since inhibitors of mucin onco proteins are potential targets for breast cancer therapy, a series of novel 4-methylthiazole-5-carboxylic acid (1) derivatives 3a-k were synthesized by the reaction of 1 with SOCl2 followed by different bases/alcohols in the presence of triethylamine. Once synthesized and characterized, their binding modes with MUC1 were studied by molecular docking analysis using Aruglab 4.0.1 and QSAR properties were determined using HyperChem. All synthesized compounds were screened for in vitro anti-breast cancer activity against MDA-MB-231 breast adenocarcinoma cell lines by Trypan-blue cell viability assay and MTT methods. Compounds 1, 3b, 3d, 3e, 3i and 3f showed good anti-breast cancer activity. Since 1 and 3d exhibited high potent activity against MDA-MB-231 cell lines, they show could be effective mucin onco protein inhibitors.

UI MeSH Term Description Entries
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Ravendra Babu Kilaru, and Koteswara Rao Valasani, and Nanda Kumar Yellapu, and Hari Prasad Osuru, and Chandra Sekhar Kuruva, and Bhaskar Matcha, and Naga Raju Chamarthi
June 2004, Bioorganic & medicinal chemistry,
Ravendra Babu Kilaru, and Koteswara Rao Valasani, and Nanda Kumar Yellapu, and Hari Prasad Osuru, and Chandra Sekhar Kuruva, and Bhaskar Matcha, and Naga Raju Chamarthi
December 2019, European journal of medicinal chemistry,
Ravendra Babu Kilaru, and Koteswara Rao Valasani, and Nanda Kumar Yellapu, and Hari Prasad Osuru, and Chandra Sekhar Kuruva, and Bhaskar Matcha, and Naga Raju Chamarthi
November 2022, Bioorganic chemistry,
Ravendra Babu Kilaru, and Koteswara Rao Valasani, and Nanda Kumar Yellapu, and Hari Prasad Osuru, and Chandra Sekhar Kuruva, and Bhaskar Matcha, and Naga Raju Chamarthi
December 2022, ACS omega,
Ravendra Babu Kilaru, and Koteswara Rao Valasani, and Nanda Kumar Yellapu, and Hari Prasad Osuru, and Chandra Sekhar Kuruva, and Bhaskar Matcha, and Naga Raju Chamarthi
April 2024, Current medicinal chemistry,
Ravendra Babu Kilaru, and Koteswara Rao Valasani, and Nanda Kumar Yellapu, and Hari Prasad Osuru, and Chandra Sekhar Kuruva, and Bhaskar Matcha, and Naga Raju Chamarthi
May 2012, Nucleosides, nucleotides & nucleic acids,
Ravendra Babu Kilaru, and Koteswara Rao Valasani, and Nanda Kumar Yellapu, and Hari Prasad Osuru, and Chandra Sekhar Kuruva, and Bhaskar Matcha, and Naga Raju Chamarthi
January 2019, Current topics in medicinal chemistry,
Ravendra Babu Kilaru, and Koteswara Rao Valasani, and Nanda Kumar Yellapu, and Hari Prasad Osuru, and Chandra Sekhar Kuruva, and Bhaskar Matcha, and Naga Raju Chamarthi
November 2011, European journal of medicinal chemistry,
Ravendra Babu Kilaru, and Koteswara Rao Valasani, and Nanda Kumar Yellapu, and Hari Prasad Osuru, and Chandra Sekhar Kuruva, and Bhaskar Matcha, and Naga Raju Chamarthi
November 2016, Bioorganic & medicinal chemistry letters,
Ravendra Babu Kilaru, and Koteswara Rao Valasani, and Nanda Kumar Yellapu, and Hari Prasad Osuru, and Chandra Sekhar Kuruva, and Bhaskar Matcha, and Naga Raju Chamarthi
February 2017, Archiv der Pharmazie,
Copied contents to your clipboard!